News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Immunotherapy is first to show survival benefit in head and neck cancer

19/04/16

The immunotherapy drug nivolumab has become the first to show a survival benefit in head and neck cancer, after a major international trial found that it was more effective than standard chemotherapy.
ICR Logo
Breast cancer can ‘reprogram’ its metabolism to resist hormone therapy

19/04/16

Cells from the most common form of breast cancer can reprogram their metabolism to help resist hormone treatments and become more aggressive, a new study shows.
Community Plaza - The London Cancer Hub
London Cancer Hub cited in report on innovation districts in capital

15/04/16

A report into London’s new knowledge economy highlights plans for The London Cancer Hub – which aims to be one of the world’s top life-science campuses specialising in cancer – as a prime example of an ‘innovation district’.
ICR Logo
Team ICR will be running the London Marathon

15/04/16

A team of 25 runners will be representing The Institute of Cancer Research, London, in the 2016 London Marathon. Their inspiring efforts will help support our world-leading cancer research.
chris tape image content
Cancer cells turn healthy cells to the ‘dark side’

14/04/16

Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread, a major new study reports.
chris tape image 4 content
Watch: How cancers turn healthy cells to the ‘dark side’

14/04/16

Through images and video, we explain new research that shows cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread.
Breast epithelial cells under ER stress (Chris Bakal, 2014)
New insights show how some breast cancers resist treatment

14/04/16

Breast cancer cells can become resistant to a common anticancer drug in a variety of different ways — suggesting that tailored treatment combinations to overcome resistance may be required for each patient.
ICR Logo
Artificial DNA could build new generation of cancer drugs

10/04/16

Scientists have built the first 3D nano-sized objects using artificial DNA, which could be used to deploy cancer treatments inside tumour cells.
Blood vessels illustration. Photo credit: Inozemtsev Konstantin/Shutterstock.com
Cancer thwarts treatment by ‘stealing’ blood vessels

07/04/16

Cancers can resist treatment by ‘stealing’ blood vessels from nearby tissues, a new study shows.
Radiotherapy IMRT Jan Chlebik/the ICR
Study predicts rare but severe side-effects after breast cancer radiotherapy

05/04/16

Small skin samples can be used to predict the likelihood of rare but severe side-effects that can occur years after radiotherapy for breast cancer, according to new research.
Professor Louis Chesler in research lab
Children with cancer to get new gene test

31/03/16

Children with cancer at leading hospitals across the UK will be offered testing for genetic mutations in their tumours as part of a new initiative to begin to personalise children’s cancer treatment.
ICR Logo
New blood test could direct pancreatic cancer treatment

30/03/16

Scientists have developed a blood test that can pick out patients with pancreatic cancer who require different types of treatment to delay progression of the disease.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.